pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

6,181 catalysts · 6,181 phase readout · 2,275 8k filing · 390 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 0 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: grant×type: filing×clear all
type
  • phase readout6,181
  • 8k filing2,275
  • earnings390
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›COMPLETEDphase readoutNCT07615569: Robot-assisted Versus Conventional Physical Therapy for Hand in Sub-acute Stroke

Sponsor: Montiha Azeem. Phase: NA. Conditions: Stroke, Spastic Hemiplegia, Upper Limb Motor Impairment

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07416669: Death, Dying, Violence and Aggression as Shown on Medical Television Series.

Sponsor: King's College Hospital NHS Trust. Phase: . Conditions: End of Life Care, Violent Aggressive Behavior, Television Viewing, Media Use

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04430569: Pulmonary Embolism International THrOmbolysis Study-3

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: PHASE3. Conditions: Pulmonary Embolism

full page →ctgov ↗
›RECRUITINGphase readoutNCT05354869: Transvaginal Electrical Stimulation for Myofascial Pelvic Pain

Sponsor: University of California, Los Angeles. Phase: NA. Conditions: Myofascial Pelvic Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT06544083: Early-stage Detection of Liver Cancer by Proteins in Peripheral Blood

Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine. Phase: . Conditions: Hepatocellular Carcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT02560883: Hairy Cell Leukemia Patient Data Registry

Sponsor: Ohio State University Comprehensive Cancer Center. Phase: . Conditions: Leukemia, Other

full page →ctgov ↗
›COMPLETEDphase readoutNCT07186283: Pharmacokinetic Study of a Novel Cannabidiol (CBD) Formulation in Healthy Volunteers

Sponsor: NW PharmaTech Ltd. Phase: PHASE1. Conditions: PK in Healthy Volunteers

full page →ctgov ↗
›TERMINATEDphase readoutNCT03939169: The Efficiency of Using Supportive Postures and Holding Techniques to Minimize Premature Infant Pain (PAP)

Sponsor: Centre Hospitalier Régional Metz-Thionville. Phase: NA. Conditions: Premature Infant

full page →ctgov ↗
›WITHHELDphase readoutNCT06210841: [Trial of device that is not approved or cleared by the U.S. FDA]

Sponsor: [Redacted]. Phase: . Conditions:

full page →ctgov ↗
›COMPLETEDphase readoutNCT00944541: Evaluation of Maraviroc Intensification in HIV Infected Patients With Insufficient Immune Restoration

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis. Phase: PHASE2. Conditions: HIV Infection, HIV Infections

full page →ctgov ↗
›RECRUITINGphase readoutNCT07001241: Telehealth Exercise Program Evaluating Fatigue and Physical Function in Rural Cancer Survivors

Sponsor: University of Colorado, Denver. Phase: PHASE2. Conditions: Cancer-related Fatigue, Breast Cancer, Prostate Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07492173: Bioequivalence Study of Trifluridine and Tipiracil Hydrochloride Tablets on Fasting and Fed in Humans

Sponsor: Shandong New Time Pharmaceutical Co., LTD. Phase: NA. Conditions: Solid Tumor Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06981169: PROPULSION SANTE: Inflammometry to Improve the Diagnostic Trajectory in Situations of Suspected Asthma in Children and Adults

Sponsor: Université de Sherbrooke. Phase: . Conditions: Asthma, Inflammation, Asthma in Children

full page →ctgov ↗
›COMPLETEDphase readoutNCT07645183: Advanced Technology for Myopia Control in Children and Young Adults

Sponsor: University of Faisalabad. Phase: NA. Conditions: Myopia (Disorder), Refraction Error

full page →ctgov ↗
›RECRUITINGphase readoutNCT05895383: Self-Adjusted Nitrous Oxide: A Feasibility Study in the Setting of Vasectomy

Sponsor: Beth Israel Deaconess Medical Center. Phase: PHASE4. Conditions: Procedural Pain, Pain Catastrophizing, Procedural Anxiety

full page →ctgov ↗
›RECRUITINGphase readoutNCT07217769: Effects of Operational Naps on Blood Pressure and Performance Among Night Shift Workers

Sponsor: University of Pittsburgh. Phase: NA. Conditions: Shift Work

full page →ctgov ↗
›RECRUITINGphase readoutNCT06571669: BOOM-IBD2 Pivotal Clinical Trial

Sponsor: Boomerang Medical. Phase: NA. Conditions: Ulcerative Colitis, Inflammatory Bowel Diseases

full page →ctgov ↗
›RECRUITINGphase readoutNCT07492641: BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease

Sponsor: BeOne Medicines. Phase: PHASE3. Conditions: HR+/HER2- Breast Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT05608083: HEARTS R34 Feasibility Study, Autistic Participants

Sponsor: Boston University Charles River Campus. Phase: NA. Conditions: Autism Spectrum Disorder

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03619083: Assessment of Sensory Gating, Attention, and Executive Control in Breast Cancer

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: . Conditions: Breast Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07749469: Safety and Efficacy of Skincare Products for Managing Mild to Moderate Acne in Individuals With Sensitive Skin

Sponsor: USMARI Research & Innovation Centre. Phase: NA. Conditions: Acne

full page →ctgov ↗
›RECRUITINGphase readoutNCT06651983: Association of Inflammatory Factors With Complications in the Diabetic Population: a Cross-sectional Study

Sponsor: Nanfang Hospital, Southern Medical University. Phase: . Conditions: Diabetes Mellitus

full page →ctgov ↗
›COMPLETEDphase readoutNCT05797441: Testing the Effectiveness of a Therapist-Assisted Self-Management Program for Veterans Who Finished PTSD Therapy

Sponsor: VA Office of Research and Development. Phase: NA. Conditions: PTSD, Post Traumatic Stress Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT05713669: Impact of Resident Participation in Post-ICU Follow Up Clinic

Sponsor: University of Michigan. Phase: NA. Conditions: Professional Burnout

full page →ctgov ↗
›RECRUITINGphase readoutNCT07597083: Biofeedback-Assisted Pelvic Floor Rehabilitation for Radiation-Induced Sexual Dysfunction in Cervical Cancer Survivors

Sponsor: Beni-Suef University. Phase: NA. Conditions: Cervical Cancer, Female Sexual Dysfunction (FSD), Radiation Induced Pelvic Floor Muscle Dysfunction

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07376083: Ultrasound vs Chest X-ray for NG Tube Placement in ICU

Sponsor: Tepecik Training and Research Hospital. Phase: . Conditions: Intensive Care (ICU)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07660341: SAD Study of CGB3002 in Healthy Participants

Sponsor: ChainGen Biopharma Ltd. Phase: PHASE1. Conditions: Alzheimer s Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT05690841: FocaL Mass Drug Administration for Vivax Malaria Elimination

Sponsor: University of California, San Francisco. Phase: PHASE3. Conditions: Plasmodium Vivax Malaria, Malaria

full page →ctgov ↗
›RECRUITINGphase readoutNCT05822141: Omega-3 Fatty Acids as Regulators of Brown Adipose Tissue During Cold Exposure

Sponsor: Indiana University. Phase: NA. Conditions: Cold Exposure

full page →ctgov ↗
›RECRUITINGphase readoutNCT07296341: HRS-4642 Combination With Other Antitumor Therapies in Patients With Solid Tumors

Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd.. Phase: PHASE1. Conditions: Locally Advanced or Metastatic Pancreatic Cancer With

full page →ctgov ↗
›COMPLETEDphase readoutNCT07204483: Feasibility Trial of Functional Clothing, Moderate Exercise, and Health Information for Stress Reduction and Behavior Change in Okinawa

Sponsor: Shinyu Kise. Phase: NA. Conditions: Obesity, Metabolic Syndrome, Stress, Psychological

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07707583: Heart Rate Variability and Medication Adherence in Resistant Hypertension

Sponsor: Nemocnice AGEL Trinec-Podlesi a.s.. Phase: . Conditions: Resistant Hypertension, Medication Adherence, Autonomic Nervous System

full page →ctgov ↗
›COMPLETEDphase readoutNCT03652441: Consolidation Therapy With Brentuximab Vedotin After Allogeneic Stem Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma

Sponsor: University of Cologne. Phase: PHASE2. Conditions: Classical Hodgkin Lymphoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT05296954: Localization of Anatomical Structures Involved in Nodal Tachycardias by High Density Mapping.

Sponsor: University Hospital, Toulouse. Phase: NA. Conditions: Atrioventricular Nodal Reentry Tachycardia, Supraventricular Tachycardia

full page →ctgov ↗
›COMPLETEDphase readoutNCT06255041: Detection of Cancer in Breath Samples by Trained Detection Dogs

Sponsor: SpotitEarly. Phase: . Conditions: Breast Cancer, Colorectal Cancer, PROSTATE CANCER, Lung Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT05515354: Smoking Cessation and Menstrual Cycle Phase

Sponsor: Centre for Addiction and Mental Health. Phase: PHASE4. Conditions: Nicotine Dependence, Tobacco Smoking, Smoking Cessation, Nicotine Use Disorder, Substance Use Disorders

full page →ctgov ↗
›COMPLETEDphase readoutNCT03343769: Study of the Relationship Between the Strength of Ankle Movement Muscles and Postural Parameters in Elderly Fallers: Towards New Strategies for Screening and Management

Sponsor: Centre Hospitalier Universitaire Dijon. Phase: . Conditions: Persons Who Have Experienced a Sudden Uncontrolled Fall in the Absence of Outside Factors in the 6 Months Preceding the Consultation

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT06940869: Network to Understand Reproductive Rheumatology Registry

Sponsor: Duke University. Phase: . Conditions: Rheumatic Diseases, Pregnancy Related, Pregnancy Interest, Reproductive Health, Autoimmune Diseases

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07397273: Acute Effects of Alpha-glycerylphosphorylcholine (A-GPC) on Lower Body Muscular Performance.

Sponsor: Northern Illinois University. Phase: NA. Conditions: Healthy Adult Participants

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04792073: Study of Avelumab and/or Radiation Therapy in People With Advanced Merkel Cell Carcinoma

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Merkel Cell Carcinoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04071769: Genentech Xenon MRI Idiopathic Pulmonary Fibrosis

Sponsor: Duke University. Phase: PHASE2. Conditions: Idiopathic Pulmonary Fibrosis

full page →ctgov ↗
›COMPLETEDphase readoutNCT03266783: Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism

Sponsor: Ottawa Hospital Research Institute. Phase: PHASE4. Conditions: Venous Thromboembolism

full page →ctgov ↗
›COMPLETEDphase readoutNCT03376269: HBOT Effect on Chronic Pain Syndrome With a History of Psychological Trauma

Sponsor: Assaf-Harofeh Medical Center. Phase: NA. Conditions: Fibromyalgia, Chronic Pain Syndrome

full page →ctgov ↗
›COMPLETEDphase readoutNCT07558070: Effect of Teach-Back-Based Discharge Education in Lower Extremity Surgery Patients

Sponsor: University of Gaziantep. Phase: NA. Conditions: Lower Extremity Surgery, Patient Education, Postoperative Care

full page →ctgov ↗
›RECRUITINGphase readoutNCT07479173: Effects of P24 on Postprandial Aminoacidemia

Sponsor: Amplifye. Phase: NA. Conditions: Postprandial Amino Acid Concentrations in Healthy Adults

full page →ctgov ↗
›RECRUITINGphase readoutNCT02328573: The Impact of Group Singing on Patients With Stroke and Their Personal Caregivers

Sponsor: Icahn School of Medicine at Mount Sinai. Phase: NA. Conditions: Stroke and Aphasia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07730073: Efficacy of LSVT-LOUD Therapy on Voice, Speech, and Quality of Life in Parkinson's Disease

Sponsor: Atlas University. Phase: NA. Conditions: Parkinson's Disease (PD)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05319873: Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer

Sponsor: Jonsson Comprehensive Cancer Center. Phase: PHASE1. Conditions: Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Carcinoma, Locally Advanced HER2-Positive Breast Carcinoma, Metastatic HER2-Positive Breast Carcinoma, Prognostic Stage IB Breast Cancer AJCC v8, Prognostic Stage II Breast Cancer AJCC v8, Prognostic Stage IIA Breast Cancer AJCC v8, Prognostic Stage IIB Breast Cancer AJCC v8, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8

full page →ctgov ↗
›RECRUITINGphase readoutNCT06502873: Setting up a Cohort of Patients With Inflammatory Bowel Disease and a Cohort of Patients Without Chronic Inflammatory Bowel Disease

Sponsor: Artialis. Phase: NA. Conditions: Inflammatory Bowel Disease (IBD)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07222969: A Clinical Study to Evaluate the Safety of VIB305 in Patients With Advanced Solid Tumors

Sponsor: Vibrant Sciences Limited. Phase: PHASE1. Conditions: Advanced Solid Tumors

full page →ctgov ↗
← prev
page 121 of 124
next →